[ad_1]
NEW DELHI: Organic E has acquired the WHO nod to be a further facility for manufacturing of Johnson & Johnson COVID-19 vaccine.
“Congratulations to @biological_e on its @WHO approval as a further manufacturing website for the Janssen/Johnson & Johnson COVID-19 vaccine! Nice progress for the Quad Vaccine and #USIndiaHealth partnerships by way of US technical assist and @DFCgov financing,” the US embassy in India mentioned in a tweet on Wednesday.
Congratulations to @biological_e on its @WHO approval as a further manufacturing website for the Janssen/Johnson & Johnson COVID-19 vaccine! Nice progress for the Quad Vaccine and #USIndiaHealth partnerships by way of U.S. technical assist and @DFCgov financing. pic.twitter.com/u35eU9YhZZ
— U.S. Embassy India (@USAndIndia) June 22, 2022
India’s first indigenously developed RBD protein subunit vaccine, Organic E’s Corbevax, is presently getting used to inoculate kids within the age group of 12 to 14 years. The Medication Controller Normal of India (DCGI) lately accepted Corbevax as a precaution dose for these aged 18 and above.
[ad_2]
Source link
